In the tumor microenvironment, particularly in cancers such as prostate cancer, AR signaling can inhibit NF-κB activity to exert anti-inflammatory effects, while NF-κB activation can suppress AR signaling, promoting cell survival and growth [17,18]. This evidence concerns the gene AR and Familial prostate cancer.